ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.

Details

Ressource 1Download: 32581069_BIB_90B1DD0DAAFD.pdf (356.38 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_90B1DD0DAAFD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
Journal
ESMO open
Author(s)
Passaro A., Addeo A., Von Garnier C., Blackhall F., Planchard D., Felip E., Dziadziuszko R., de Marinis F., Reck M., Bouchaab H., Peters S.
ISSN
2059-7029 (Electronic)
ISSN-L
2059-7029
Publication state
Published
Issued date
06/2020
Peer-reviewed
Oui
Volume
5
Number
Suppl 3
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. Within this framework, it is crucial to ensure no disruption to essential oncological services and guarantee the optimal care.This is a structured proposal for the management of lung cancer, comprising three levels of priorities, namely: tier 1 (high priority), tier 2 (medium priority) and tier 3 (low priority)-defined according to the criteria of the Cancer Care Ontario, Huntsman Cancer Institute and Magnitude of Clinical Benefit Scale.The manuscript emphasises the impact of the COVID-19 pandemic on lung cancer care and reconsiders all steps from diagnosis, staging and treatment.These recommendations should, therefore, serve as guidance for prioritising the different aspects of cancer care to mitigate the possible negative impact of the COVID-19 pandemic on the management of our patients.As the situation is rapidly evolving, practical actions are required to guarantee the best patients' treatment while protecting and respecting their rights, safety and well-being. In this environment, cancer practitioners have great responsibilities: provide timely, appropriate, compassionate and justified cancer care, while protecting themselves and their patients from being infected with COVID-19. In case of shortages, resources must be distributed fairly. Consequently, the following recommendations can be applied with significant nuances, depending on the time and location for their use, considering variable constraints imposed to the health systems. An exceptional flexibility is required from cancer caregivers.
Keywords
Ambulatory Care, Betacoronavirus, Carcinoma, Non-Small-Cell Lung/pathology, Carcinoma, Non-Small-Cell Lung/therapy, Chemoradiotherapy, Coronavirus Infections/epidemiology, Delivery of Health Care/methods, Humans, Lung Neoplasms/pathology, Lung Neoplasms/therapy, Medical Oncology, Neoplasm Staging, Pandemics, Pneumonectomy, Pneumonia, Viral/epidemiology, Practice Guidelines as Topic, Radiation Oncology, Radiosurgery, Small Cell Lung Carcinoma/pathology, Small Cell Lung Carcinoma/therapy, Surgical Oncology, Telemedicine, Time-to-Treatment, Tomography, X-Ray Computed, Triage, COVID19, SARS-CoV-2, lung cancer
Pubmed
Open Access
Yes
Create date
08/07/2020 12:40
Last modification date
30/04/2021 6:12
Usage data